UnknownPhase 4

ERAS Protocol for Single-level Posterior Lumbar Arthrodesisprospective Study.

Belgium110 participantsStarted 2021-07-08

Plain-language summary

Enhanced Recovery After Surgery (ERAS) is a multidisciplinary, multimodal approach aiming to improve surgical outcomes. This study compares the length of hospital stay of patients undergoing single-level posterior lumbar arthrodesis and treated with the ERAS protocol with the hospital stay of patients treated according to the standard protocol.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Scheduled for a single level PLIA as treatment of mono segmental degenerative instability, as seen on dynamic X-rays, after the failure of 6 months conservative therapy Capable of understanding the provided information Giving informed consent Exclusion Criteria: * Revision surgery Arthrodesis for trauma, neoplasms, infection, or listhesis due to lysis. High dose opioid use (step 3 of the WHO pain ladder) Diabetes Cognitive impairment (baseline dementia, cognitive dysfunction, or inability to consent to participate). Known kidney insufficiency: GFR \<30 mL/min/1.73 m2 Allergy/intolerance/contraindication to any medication or component included in the ERAS pathway protocol Patients with a risk factor for reflux

What they're measuring

Length of hospital stay

Timeframe: 2-3 days + 11 days

Trial details

NCT IDNCT05022745

SponsorAZ Nikolaas

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-08

Contact for this trial

Erik Van de Kelft, MD, PhD

+32 3 760 21 72 Erik.vandeKelft@aznikolaas.be

View on ClinicalTrials.gov More Mobility trials